UK markets closed
NIKKEI 225
33,321.22 -87.17 (-0.26%) HANG SENG
16,993.44 -360.70 (-2.08%) CRUDE OIL
77.58 +1.17 (+1.53%) GOLD FUTURES
2,068.70 +8.50 (+0.41%) DOW
35,554.05 +137.07 (+0.39%) Bitcoin GBP
29,751.17 -110.95 (-0.37%)
GSK Jan 2024 35.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:54AM EST. Market open.
| Previous close | 1.5000 |
| Open | 1.4000 |
| Bid | 1.4000 |
| Ask | 1.4500 |
| Strike | 35.00 |
| Expiry date | 2024-01-19 |
| Day's range | 1.3500 - 1.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 6.13k |
ZacksGSK Key Drugs & Vaccines Help Stock Outperform Industry YTD
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates are expected drive the stock in the future quarters.
Motley Fool3 Great Foreign Companies to Invest in Right Now
This quote has been attributed both to Mark Twain and Ambrose Bierce, and it may not have been uttered or written by either. Here are three foreign companies to consider for your portfolio. If you're familiar with and hopeful about fintech companies, such as PayPal, get to know Adyen (OTC: ADYE.Y) (OTC: ADYY.F).
CityAMGSK’s blood cancer drug shows promise in late-stage trial
GSK said on Monday its blood cancer drug Blenrep, when used as a second-line treatment in patients with myeloma, met its primary goal.
© 2023 Yahoo. All rights reserved.